BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25093603)

  • 21. Prospective randomized comparison of tongue base resection techniques: Robotic vs coblation.
    Babademez MA; Gul F; Sancak M; Kale H
    Clin Otolaryngol; 2019 Nov; 44(6):989-996. PubMed ID: 31464082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncological outcome following initiation of treatment for stage III and IV HPV negative oropharyngeal cancers with transoral robotic surgery (TORS).
    Dabas S; Gupta K; Sharma AK; Shukla H; Ranjan R; Sharma DK
    Eur J Surg Oncol; 2019 Nov; 45(11):2137-2142. PubMed ID: 31239156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term postoperative distress associated with open vs. transoral robotic surgery (TORS) in patients with T1-T2 carcinomas of the tongue base and supraglottis.
    Slama K; Slouka D; Slipka J; Fischer S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):423-8. PubMed ID: 26996243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of tongue base masses in children by transoral robotic surgery.
    Kayhan FT; Yigider AP; Koc AK; Kaya KH; Erdim I
    Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3457-3463. PubMed ID: 28625010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysis.
    de Almeida JR; Moskowitz AJ; Miles BA; Goldstein DP; Teng MS; Sikora AG; Gupta V; Posner M; Genden EM
    Head Neck; 2016 Apr; 38(4):589-600. PubMed ID: 25488048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National trends in oropharyngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care.
    Gourin CG; Frick KD
    Laryngoscope; 2012 Mar; 122(3):543-51. PubMed ID: 22241647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
    Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robotic Tongue-Base Resection Combined With Tongue-Base Suspension for Obstructive Sleep Apnea.
    Turhan M; Bostanci A
    Laryngoscope; 2020 Sep; 130(9):2285-2291. PubMed ID: 31782809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transoral robotic surgery (TORS) for tongue base tumours.
    Mercante G; Ruscito P; Pellini R; Cristalli G; Spriano G
    Acta Otorhinolaryngol Ital; 2013 Aug; 33(4):230-5. PubMed ID: 24043909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-utility of two minimally-invasive surgical techniques for operable oropharyngeal cancer: transoral robotic surgery versus transoral laser microsurgery.
    Parimbelli E; Soldati F; Duchoud L; Armas GL; de Almeida J; Broglie M; Quaglini S; Simon C
    BMC Health Serv Res; 2021 Oct; 21(1):1173. PubMed ID: 34711226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for gastrostomy tube dependence in transoral robotic surgery patients.
    Philips R; Topf MC; Vimawala S; Luginbuhl A; Curry JM; Cognetti DM
    Am J Otolaryngol; 2022; 43(1):103175. PubMed ID: 34418824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staged neck dissection prior to transoral robotic surgery for oropharyngeal cancer: does it reduce post-operative complication rates? A multi-centre study of 104 patients.
    Blom M; Zhang H; Tescher A; Dixon B; Magarey M
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):5067-5072. PubMed ID: 37561189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Lörincz BB; Möckelmann N; Busch CJ; Knecht R
    Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell Carcinoma.
    Persky MJ; Albergotti WG; Rath TJ; Kubik MW; Abberbock S; Geltzeiler M; Kim S; Duvvuri U; Ferris RL
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):660-666. PubMed ID: 29182490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transoral robotic surgery for treatment of obstructive sleep apnea: factors predicting surgical response.
    Lin HS; Rowley JA; Folbe AJ; Yoo GH; Badr MS; Chen W
    Laryngoscope; 2015 Apr; 125(4):1013-20. PubMed ID: 25346038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Effectiveness Analysis of Radiation Therapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
    Rodin D; Caulley L; Burger E; Kim J; Johnson-Obaseki S; Palma D; Louie AV; Hansen A; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):709-717. PubMed ID: 28244405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
    Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
    Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anesthesia for TORS for Oropharyngeal Carcinoma: Factors Associated with Prolonged Phase I Postanesthesia Recovery.
    Puccinelli CL; Moore EJ; Yin LX; Price DL; Janus JR; Weingarten TN; Van Abel KM
    Otolaryngol Head Neck Surg; 2020 Sep; 163(3):531-537. PubMed ID: 32312161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.